Abstract
Nonsevere hypoglycemia in people with diabetes is usually treated with rapid-acting carbohydrate, of which glucose is the most suitable form. A quantity of 15
g is recommended and repeated after 15 min if hypoglycemia persists. This recommendation
has not changed for several years despite the introduction of continuous glucose monitoring,
newer and more flexible insulin regimens and improved insulin delivery. The present
review has examined published studies that have explored how effectively defined amounts
of carbohydrate treat nonsevere hypoglycemia in adults with insulin-treated diabetes.
For most nonsevere episodes of hypoglycemia, the optimal treatment is 15 to 20 g of
oral glucose. However, this dose may not be appropriate with many current insulins
and insulin pump therapy, where doses of glucose may have to be individualized, and
based on body weight or the type of insulin delivery system. Current guidelines on
hypoglycemia treatment for newer glucose-lowering therapies may require re-evaluation.
RÉSUMÉ
Le traitement de l’hypoglycémie bénigne chez les personnes diabétiques repose généralement
sur les glucides à absorption rapide desquels le glucose est la forme la plus appropriée.
Une quantité de 15 g est recommandée et répétée après 15 min si l’hypoglycémie persiste.
Cette recommandation n’a pas changé depuis plusieurs années en dépit de l’instauration
de la surveillance de la glycémie en continu, des schémas posologiques plus récents
et plus flexibles et de l’administration améliorée de l’insuline. La présente revue
a porté sur les études publiées qui se sont penchées sur la façon dont des quantités
bien définies de glucides contribuent au traitement de l’hypoglycémie bénigne chez
les adultes diabétiques traités par insuline. Dans la plupart des épisodes d’hypoglycémie
bénigne, le traitement optimal est de 15 à 20 g de glucose par voie orale. Toutefois,
cette dose ne convient pas aux nombreuses insulines actuelles et au traitement par
pompe à insuline dont les doses de glucose peuvent devoir être individualisées, et
ajustées en fonction du poids corporel ou du type de système d’administration d’insuline.
Les lignes directrices actuelles sur le traitement de l’hypoglycémie par les plus
récents traitements hypoglycémiants doivent faire l’objet d’une ré-évaluation.
Keywords
Mots clés
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of DiabetesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The barrier of hypoglycemia in diabetes.Diabetes. 2008; 57: 3169-3176
- Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: A joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes.Diabetes Care. 2017; 40: 155-157
- 6. Glycemic Targets: Standards of Medical Care in Diabetes–2022.Diabetes Care. 2022; 45: S83-S96
- Canadian Diabetes Association Clinical Practice Guidelines Expert Committee; Clayton D, Woo V, Yale JF. Hypoglycemia.Can J Diabetes. 2013; 37: S69-S71
- The hospital management of hypoglycaemia in adults with diabetes mellitus.2022. ABCD (Diabetes Care) Ltd., 2022https://abcd.care/resource/jbds-01-hospital-management-hypoglycaemia-adults-diabetes-mellitusDate accessed: December 10, 2021
- CG18. Diabetes (type 1 and type 2) in children and young people: diagnosis and management.www.nice.org.uk/guidance/ngDate accessed: August 18, 2015
- General practice management of type 2 diabetes.https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/5d3298b2-abf3-487e-9d5e-0558566fc242.pdfDate accessed: December 10, 2021
- Pharmacologic glycemic management of type 2 diabetes in adults.Can J Diabetes. 2018; 42: S88-S103
- Treatment of insulin reactions in diabetics.JAMA. 1984; 252: 3378-3381
- The search for an optimized treatment of hypoglycemia.Arch Intern Med. 1990; 150: 589-593
- Dietary treatment of hypoglycaemia: Should the Australian recommendation be increased?.Intern Med J. 2012; 42: 830-833
- Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: Are current recommendations effective?.Acta Diabetol. 2018; 55: 227-231
- Effect of carbohydrate treatment on mild symptomatic hypoglycaemia, assessed by continuous glucose monitoring.European Diabetes Nursing. 2006; 3: 143-146
- Predictive low-glucose suspend necessitates less carbohydrate supplementation to rescue hypoglycemia: Need to revisit current hypoglycemia treatment guidelines.Diabetes Technol Ther. 2021; 23: 512-516
- Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile.Diabetes Metab Syndr. 2021; 15: 695-701
- Weight-based hypoglycaemia treatment protocol for adults with type 1 diabetes: A randomized crossover clinical trial.Diabet Med. 2015; 32: 1143-1148
- Weight-based carbohydrate treatment of hypoglycaemia in people with type 1 diabetes using insulin pump therapy: A randomized crossover clinical trial.Diabet Med. 2018; 35: 339-346
- Optimizing the management of hypoglycaemia in individuals with type 2 diabetes: A randomized crossover comparison of a weight-based protocol compared with two fixed-dose glucose regimens.Diabetes Obes Metab. 2018; 20: 1256-1261
- Characterization of individualized glycemic excursions during a standardized bout of hypoglycemia-inducing exercise and subsequent hypoglycemia treatment—A pilot study.Nutrients. 2021; 13: 4165
- Hypoglycaemia, cardiovascular disease, and mortality in diabetes: Epidemiology, pathogenesis and management.Lancet Diabetes Endocrinol. 2019; 7: 385-396
- Hypoglycemia.in: Bonora E. DeFronzo R. Diabetes complications, comorbidities and related disorders. Springer, Cham2020: 615-652
- The effectiveness of glucose, sucrose, and fructose in treating hypoglycaemia in children with type 1 diabetes.Pediatr Diabetes. 2009; 11: 154-158
- Effective treatment of hypoglycaemia in children with type 1 diabetes: A randomized controlled clinical trial.Pediatr Diabetes. 2011; 12: 381-387
- Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial.Diabetes Care. 2001; 24: 1711-1721
Article Info
Publication History
Published online: April 06, 2022
Accepted:
March 29,
2022
Received in revised form:
January 3,
2022
Received:
June 22,
2021
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2022 Canadian Diabetes Association.
